课题基金 / 基金详情

Protection of Ischemic/Traumatic Brain Injruy in SOD-Transgenic Mouse

Protection of Ischemic/Traumatic Brain Injruy in SOD-Transgenic Mouse
SOD 转基因小鼠缺血/创伤性脑损伤的保护作用
批准号:
06044024
负责人:
YOSHIMOTO Takashi
金额:
$2.82万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 --

项目摘要

项目成果

YOSHIMOTO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Oxygen-derived free radicals have been implicated in the pathogenesis of vasogenic edema and infarction caused by ischemia. Liposome-entrapped CuZn superoxide dismutase (SOD) ameliorated ischemic brain edema and infarction in rats. Although these studies provide potential therapeutic precedents for the management of brain injury, alternative experimental approaches are neede to address the issues of the role of oxygen free radicals and the mode of action of SOD in ischemic brain injury. To investigate directly the increased brain CuZn-SOD in the pathogenesis of brain injuries presumed to involve superoxide radicals, we have used trangenic (Tg) mice carrying the human CuZn-SOD gene.First, We have compared the c-fos protooncogene and 70kDa-heat shock protein (hsp70) mRNA induction between Tg mouse (3.1 fold increased SOD activity) and nonTg mouse following 10min and 60 min of middle cerebral artery (MCA) occlusion. And also we have examined the effect of nitric oxide synthase (NOS) inhib … More itors, L-NAME (neuronal and endothelial NOS inhibitor) and 7-NI (selective neuronal NOS inhibitor) and 7-NI (selective neuronal NOS inhibitor) on brain infarction in both mice, since nitric oxide (NO) has been considered to react with superoxide radicals and form peroxynitrite, a strong oxidant. In 60min ischemia the area of c-fos and hsp70 mRNA induction was significantly attenuated in Tg mice than nonTg mice. However, the prolonged expression of c-fos and hsp70 mRNA was demonstrated in Tg mice compared to nonTg mice after the recircualtion following 10min MCA occlusion. In the NOS inhibitor experiment, L-NAME treated-Tg mice showed significantly bigger infarct volume than saline-treated ones, whereas 7-NI showed the tendency to decrease the infarction in Tg mice. These resuts suggest that SOD could protect brain from severe ischemic insults causing infarction and that the NO generated by neuronal NOS results in the brain injury depending the superoxide content.Secondarily, it was also investigated that the brain edema formation and the induction of hsp70 and c-fos mRNA following traumatic injury using nonTg mice, and heterozygous and homozygous Tg mice (1.5,3.1, and 5.0 fold increased SOD activityies. The water content of injured parietal cortex and Evans Blue dye leakage were attenuated in Tg mice in a SOD dose dependent manner. The areas of hsp70 and c-fos mRNA induction were smaller in Tg mice than in nonTg mice following injury. In chronic stage, the neurological function was significantly improved in Tg mice compared to nonTg mice.Finally, we have measured the electrical resistance through the single layr of the brain endothelial cell culture from Tg and/or nonTg mice following the treatment with superoxide generating agent, menadion, in order to evaluate the effect of superoxide on the BBB permeability. Adversely, the permeability was significantly increased in Tg than nonTg mice. This increase is likely due to the depletion of scavenging system of hydrogen peroxide and forming hydroxyl radical through superoxide-dirven Fenton type Haber-Weise reaction since this increase was antagonized by adding desferroxamine.From these results, the increase of SOD activity could be toxic by generating hydroxyl radicals under the special circumstance although SOD has a strong brain protective effect against the ischemic and traumatic insult in vivo. And it is also suggested that the scavenging system of hydrogen peroxide is essential for SOD to perform the protective effect by eliminating superoxide radicals. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hideyuki Kamii: "Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice" Brain Research. 662. 240-244 (1994)
Hideyuki Kamii:“SOD-1 转基因小鼠轻度局灶性脑缺血后 c-fos mRNA 的表达”大脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
今泉茂樹: "VASOSPASM GRAND ROUND(CVD GRAND ROUND SERIES VOL1)" ニューロン社, 192 (1994)
今泉茂树:“VASOSPASM GRAND ROUND(CVD GRAND ROUND SERIES VOL1)”Neuronsha,192 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    DEVELOPMENT OF THE ENDOVASCULAR THROMBOLYSIS SYSTEM WITH SHOCK WAVE
    • 批准号:
      12307028
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $11.9万
    • 财政年份:
      2000
    • 负责人:
      YOSHIMOTO Takashi
    • 依托单位:
    Development of intravascular shock wave thrombolysis for cerebral embolism
    • 批准号:
      11357014
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $14.72万
    • 财政年份:
      1999
    • 负责人:
      YOSHIMOTO Takashi
    • 依托单位:
    Less Invasive Treatment for intractable Epilepsy Combined with Magnetoencephalography and Radiosurgery
    • 批准号:
      09307030
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $15.1万
    • 财政年份:
      1997
    • 负责人:
      YOSHIMOTO Takashi
    • 依托单位:
    Basic Study of sound-dynamic Therapy for Atherosclerotic Cerebrovascular Disease.
    • 批准号:
      07557254
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $2.18万
    • 财政年份:
      1995
    • 负责人:
      YOSHIMOTO Takashi
    • 依托单位:
    国内基金
    海外基金
    缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
    • 批准号:
      82370751
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张明
    • 依托单位:
    骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
    • 批准号:
      82371301
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李轶
    • 依托单位:
    TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
    • 批准号:
      82371142
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      刘君
    • 依托单位:
    基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题